TIG Advisors »

BioMarin Pharmaceutical shares owned by TIG Advisors

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by TIG Advisors from 13F filings

Historical chart of TIG Advisors investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by TIG Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by TIG Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.1M 53k 96.42

More positions owned by TIG Advisors

United States Steel Corporation Put Option (X)
Capri Holdings SHS (CPRI)
stock
ImmunoGen
Ansys Call Option (ANSS)
Endeavor Group Hldgs Cl A Com Put Option (EDR)
Pioneer Natural Resources (PXD)
Albertsons Cos Common Stock Put Option (ACI)
Cleveland-cliffs (CLF)
Chevron Corporation (CVX)
Cytokinetics Com New Call Option (CYTK)
Argenx Se Sponsored Adr Call Option (ARGX)
Apellis Pharmaceuticals (APLS)
Gracell Biotechnologies Sponsored Ads
Neurocrine Biosciences Call Option (NBIX)

View all positions for TIG Advisors

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
Dodge & Cox
Barclays
Viking Global Investors
venBio Select Advisor
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management
Elliott Investment Management
Henderson Group
Bank of New York Mellon
Jpmorgan Chase & Co
Bank of America Corporation
Nomura Holdings
Parnassus Investments

View all funds holding BioMarin Pharmaceutical